Literature DB >> 11382946

MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation.

P T Weatherall1, G F Evans, G J Metzger, M H Saborrian, A M Leitch.   

Abstract

Twenty consecutive patients with breast cancer were evaluated following chemotherapy using MRI to assess the size of cancer residua and compare these data with subsequent histologic measurements of the viable tumor. This retrospective study also involved assessment of the preoperative size of the malignancy as determined by physical exam and x-ray mammogram. These values were later compared with the histology. The tumor size correlation coefficient between MRI and pathologic analysis was the highest, at 0.93. Physical exam and x-ray mammography (available for 17 patients) produced correlation coefficients of 0.72 and 0.63, respectively, compared to histologic measurement. The accuracy of MRI did not vary with the size of cancer residua. MRI is an accurate method for preoperative assessment of breast cancer residua following chemotherapy. J. Magn. Reson. Imaging 2001;13:868-875. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11382946     DOI: 10.1002/jmri.1124

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  40 in total

1.  Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy.

Authors:  H J Shin; H H Kim; J H Ahn; S-B Kim; K H Jung; G Gong; B H Son; S H Ahn
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

2.  Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.

Authors:  Wendie A Berg; Kathleen S Madsen; Kathy Schilling; Marie Tartar; Etta D Pisano; Linda Hovanessian Larsen; Deepa Narayanan; Al Ozonoff; Joel P Miller; Judith E Kalinyak
Journal:  Radiology       Date:  2010-11-12       Impact factor: 11.105

3.  Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy.

Authors:  Ai Amioka; Norio Masumoto; Noriko Gouda; Keiko Kajitani; Hideo Shigematsu; Akiko Emi; Takayuki Kadoya; Morihito Okada
Journal:  Jpn J Clin Oncol       Date:  2016-02-03       Impact factor: 3.019

Review 4.  Incorporating new imaging models in breast cancer management.

Authors:  Denise H Reddy; Ellen B Mendelson
Journal:  Curr Treat Options Oncol       Date:  2005-03

5.  Development of array piezoelectric fingers towards in vivo breast tumor detection.

Authors:  Xin Xu; Youngsoo Chung; Ari D Brooks; Wei-Heng Shih; Wan Y Shih
Journal:  Rev Sci Instrum       Date:  2016-12       Impact factor: 1.523

6.  3D multi-parametric breast MRI segmentation using hierarchical support vector machine with coil sensitivity correction.

Authors:  Yi Wang; Glen Morrell; Marta E Heibrun; Allison Payne; Dennis L Parker
Journal:  Acad Radiol       Date:  2012-10-23       Impact factor: 3.173

7.  Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization.

Authors:  Quing Zhu; Susan Tannenbaum; Poornima Hegde; Mark Kane; Chen Xu; Scott H Kurtzman
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

8.  A model study of 3-dimensional localization of breast tumors using piezoelectric fingers of different probe sizes.

Authors:  Xin Xu; Wei-Heng Shih; Wan Y Shih
Journal:  Rev Sci Instrum       Date:  2019-01       Impact factor: 1.523

Review 9.  Multiparametric MR Imaging of Breast Cancer.

Authors:  Habib Rahbar; Savannah C Partridge
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

10.  Current Status and Future Prospects of Proton MR Spectroscopy of the Breast with a 1.5T MR Unit.

Authors:  Mitsuhiro Tozaki; Katsuya Maruyama
Journal:  J Oncol       Date:  2010-09-26       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.